Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7
Cervical cancer is a leading cause of high mortality in women in developing countries and has a serious impact on women’s health. Human papilloma virus (HPV) prophylactic vaccines have been produced and may hold promise for reducing the incidence of cervical cancer. However, the limitations of curre...
Main Authors: | Feifei Duan, Jiaqi Chen, Hao Yao, Yuting Wang, Yanyan Jia, Zhiting Ling, Youwei Feng, Zhiming Pan, Yuelan Yin, Xin’An Jiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1839291 |
Similar Items
-
A Cross-Protective Vaccine Against 4b and 1/2b Listeria monocytogenes
by: Fanzeng Meng, et al.
Published: (2020-12-01) -
inlF Enhances Listeria monocytogenes Early-Stage Infection by Inhibiting the Inflammatory Response
by: Zhiting Ling, et al.
Published: (2022-02-01) -
A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner
by: Yan Yan Jia, et al.
Published: (2017-06-01) -
Rapid Detection of Hypervirulent Serovar 4h Listeria monocytogenes by Multiplex PCR
by: Youwei Feng, et al.
Published: (2020-06-01) -
Handbook of listeria monocytogenes /
by: Liu, Dongyou
Published: (2008)